Dr. Schaeffer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N Saint Clair St
Chicago, IL 60611Phone+1 312-695-8146Fax+1 312-695-7030
Summary
- I am Chair of the Department of Urology at Feinberg School of Medicine and Program Director of the Genitourinary Oncology Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. I am a clinically active urologist with a specialized practice in prostate cancer. My prostate cancer research focuses on at-risk populations, diagnosis, treatment outcomes, and the molecular biology of lethal prostate cancer.
Education & Training
Johns Hopkins UniversityResidency, Urology, 2002 - 2007- Johns Hopkins UniversityInternship, Surgery, 2001 - 2002
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2001
Certifications & Licensure
MI State Medical License 2024 - 2027
IL State Medical License 2015 - 2026
AZ State Medical License 2024 - 2025
IN State Medical License 2024 - 2025
WI State Medical License 2024 - 2025
TX State Medical License 2024 - 2024
MD State Medical License 2007 - 2017- American Board of Urology Urology
Awards, Honors, & Recognition
- Chair, Prostate Cancer Guidelines Committee National Comprehensive Cancer Network
- Rising Star in Urology AUA / Astellas
- Top Doc Baltimore Magazine, 2014
- Join now to see all
Publications & Presentations
PubMed
- 93 citationsProstate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.Edward M Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Daniel Barocas
Journal of the National Comprehensive Cancer Network. 2023-10-01 - 13 citationsOptimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy naïve men.Mohammad R Siddiqui, Eric V Li, Sai K S R Kumar, Anna Busza, Jasmine S Lin
Prostate Cancer and Prostatic Diseases. 2023-09-01 - 57 citationsUse of the Prostate Health Index for detection of prostate cancer: results from a large academic practiceJeffrey J. Tosoian, Sasha C. Druskin, Darian Andreas, Patrick Mullane, Meera Chappidi
Prostate Cancer and Prostatic Diseases. 2017-01-24
Journal Articles
- Original Contribution TP53 Missense Mutation Is Associated with Increased Tumor-Infiltrating T-cells in Primary Prostate Cancer☆Tamara L Lotan, Mario Eisenberger, Harsimar B Kaur, Scott A Tomlins, Edward M Schaeffer, ScienceDirect
- “Real-World” Practice Makes Perfect: Ensuring the Active Component of Active Surveillance for Prostate CancerEdward M Schaeffer, Scott E Eggener, European Urology
- Transcriptomic Heterogeneity of Favorable-Risk Prostate Cancer: Time to Move Past Cancer of the Prostate Risk Assessment (CAPRA) to Clinical-Genomic RiskEdward Schaeffer, MD, European Urology
- Join now to see all
Authored Content
- SUO 2020: Prostate and Bladder Cancer UpdatesDecember 2020
- Association of Presalvage Radiotherapy PSA Levels After Prostatectomy with Outcomes of Long-Term Antiandrogen Therapy in Men with Prostate CancerMarch 2020
- Clinical and Genomic Characterization of Low–Prostate-Specific Antigen, High-Grade Prostate CancerFebruary 2018
Press Mentions
Study Advocates for Alternative Biopsy Approach to Detecting Prostate CancerSeptember 30th, 2024- Transperineal Biopsies Show Superior Safety over Transrectal MethodSeptember 19th, 2024
- Combination Treatment Extends Survival in Advanced Bladder CancerSeptember 17th, 2024
- Join now to see all
Professional Memberships
- Member
External Links
- Northwestern Urologyhttp://news.feinberg.northwestern.edu/2015/09/new-chair-of-urology-named/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
